Nu Skin said a strong dollar negatively affected its full-year revenue by more than $100 million
Nu Skin shares tumbled 3.01% to $43.23 in pre-market trading Thursday after the company reported weaker than expected fourth-quarter results. Though its revenues edged past the Wall Street estimates, earnings fell short. The personal care products maker reported $609.6 million in sales, beating the consensus estimate of $599.88 million. Nu Skin had generated $1.06 billion revenue in the corresponding quarter a year ago. The Q4, 2013 revenue was boosted by $350 million in limited time offer sales of its ageLOC TR90 weight management system.
Nu Skin’s Greater China revenue falls 56%
Revenue in Greater China witnessed a whopping 56% decline. The Provo-based company said forex fluctuations affected its Q4 revenue by 4%. However, its earnings plunged 63% YoY in a major disappointment to investors. Nu Skin earned $46.5 million or 77 cents per share, down from 125.3 million or $2.02 per share in the corresponding quarter last year. The company said its Q4 earnings were affected by forex fluctuations and prepayment fees associated with its debt refinancing.
For full-year 2014, the company generated $2.57 billion in revenue, down 19% from the previous year. Full-year earnings came in at $3.11 per share, missing analysts’ projection of $4.10 per share. Nu Skin said a strong dollar negatively affected its full-year revenue by more than $100 million. Operating margin declined from 17.9% in Q4, 2013 to 15% in the latest quarter.
Top value fund managers are ready for the small cap bear market to be done
During the bull market, small caps haven't been performing well, but some believe that could be about to change. Breach Inlet Founder and Portfolio Manager Chris Colvin and Gradient Investments President Michael Binger both expect small caps to take off. Q1 2020 hedge fund letters, conferences and more However, not everyone is convinced. BTIG strategist Read More
Nu Skin issues weak guidance
Nu Skin’s gross margins also fell from 84.4% to 82.5%. The company ended the quarter with $300.2 million in cash and cash equivalents, and $247.3 million of debts on its balance sheet. For the current quarter, Nu Skin guided revenue of $530 million to $550 million, lower than the consensus estimate of $568.37 million. It expects Q1 earnings between 70 and 74 cents a share, much lower than analysts’ projection of 91 cents.
Nu Skin announced that its board of directors has increased the quarterly dividend from $0.345 to $0.35 per share. The quarterly dividend will be paid on March 18 to shareholders of record on February 27.
Nu Skin shares were down 2.83% to $43.31 in pre-market trading. The stock has declined more than 23% in the past six months.